聚焦超声响应的人造杀手细胞用于增强闭环癌症免疫疗法
Jieying Zhang1, Pengrui Wang1, Lingkai Meng1
1School of Physical Science and Technology, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, 201210, P. R. China. zhuxj1@shanghaitech.edu.cn.
Materials horizons
|July 10, 2025
概括
聚焦超声波 (FUS) 响应的人造杀手细胞 (AKC) 通过整合多个免疫细胞功能来增强癌症免疫疗法. 这种新的系统可以改善瘤向,并激活免疫反应,以延长存活时间和瘤回归.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 目前的免疫疗法面临着诸如免疫激活不足和有限的瘤透等挑战.
- 人工杀手细胞 (AKC) 提供了一种新的仿生方法来克服这些局限性.
研究的目的:
- 开发聚焦超声波 (FUS) 响应的人造杀手细胞 (AKCs),用于增强闭环瘤免疫治疗.
- 将自然杀手 (NK) 细胞,树突细胞 (DC) 和巨细胞功能整合到一个平台上.
- 通过使用先进的仿生策略来改善瘤向,保留和治疗疗效.
主要方法:
- 在混合脂质膜中使用兰化物纳米粒子构建的AKC用于生物相容性和近红外 (NIR) 成像.
- 利用FUS控制释放铜和RANTES细胞因子来招募树突细胞 (DCs).
- 在携带瘤的小鼠中评估了AKC的性能,评估瘤向,保留,免疫激活和治疗结果.
主要成果:
- 与传统的脂质体配方相比,AKCs表现出优异的瘤向和保留.
- 由FUS诱导的铜释放和RANTES细胞因子招募有效地改变了免疫抑制性瘤微环境.
- 通过AKCs诱导cuproptosis显著增强了瘤消除,导致老鼠的生存时间延长和瘤回归.
结论:
- 对FUS敏感的AKC通过结合先天性和自适应性免疫激活,在向癌症治疗中代表了有前途的进步.
- 这种多方面的方法为克服免疫治疗挑战和改善临床结果提供了一种新的策略.
- 综合系统强调了仿生设计在开发下一代癌症治疗的潜力.
更多相关视频
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
1.0K
08:12Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 11, 2014
9.8K
相关概念视频
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Cytotoxic T Cells-mediated Immune Response
2.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
